[Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra)].
Hayashi
Hidetoshi
H
Graduate School of Pharmaceutical Sciences, Nagoya City University.
Onozaki
Kikuo
K
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000175:diagnosis; D001681:Biological Assay / Q000379:methods; D015415:Biomarkers / Q000097:blood; D006073:Gout / Q000175:diagnosis; D006801:Humans; D007118:Immunoassay / Q000379:methods; D007249:Inflammation / Q000175:diagnosis*; D007375:Interleukin-1 / Q000097:blood* / Q000502:physiology; D009080:Mucocutaneous Lymph Node Syndrome / Q000175:diagnosis; D010024:Osteoporosis / Q000175:diagnosis; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors* / Q000097:blood* / Q000502:physiology; D012016:Reference Values; D012772:Shock, Septic / Q000175:diagnosis; D013048:Specimen Handling
D015415:Biomarkers; D007375:Interleukin-1; D017472:Receptors, Interleukin-1